Major trial tests tailored, intensive therapies to fight aggressive blood cancers
NCT ID NCT02881086
Summary
This large study aimed to find the best treatment plans for adults newly diagnosed with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. It tested personalized, intensive chemotherapy approaches, including a specific drug (nelarabine) for a certain type of ALL, and evaluated whether stem cell transplants or avoiding brain radiation were better for some patients. The goal was to control the cancer more effectively and improve long-term survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Frankfurt (Main)
Frankfurt am Main, 60590, Germany
Conditions
Explore the condition pages connected to this study.